Insurance

Updated:

REVIUM Rückversicherung

REVIUM Rückversicherung manages venture capital through the captive reinsurance arm of B.

REVIUM Rückversicherung

REVIUM Rückversicherung was founded in 2007 as a wholly owned subsidiary of B. Braun SE, the Melsungen-based medical technology group controlled by the Braun family since 1839. The parent company, led by sixth-generation CEO Anna Maria Braun, generated €9.4 billion in group sales in fiscal year 2025. Ludwig Georg Braun, Anna Maria's father and the long-time former CEO, now serves as Chairman of the Supervisory Board, overseeing the family's industrial and financial assets, which include reinsurance operations and board seats at Stihl AG, WIKUS-Sägenfabrik, and Wilhelm Werhahn KG. REVIUM manages a reinsurance portfolio that stems from premiums generated across the B. Braun Group's global healthcare operations. The firm directs that capital into a venture investment strategy that spans early-stage seed and start-up rounds through expansion and late-stage commitments. Unlike most corporate captives that outsource asset management, REVIUM executes a direct investment program from Melsungen, targeting companies that may align with or adjacent to the parent's core competency in medical technology. The firm's investment posture is generalist within venture, with no public disclosures limiting sector exposure. The firm's investment footprint remains rooted in Germany, with its sole office at B. Braun's headquarters on Carl-Braun-Straße in Melsungen. Ludwig Georg Braun's extensive network — built through his own leadership of B. Braun and supervisory roles at peer industrial groups — provides REVIUM with access to deal flow across the German Mittelstand and beyond. The B. Braun Group also maintains the B. Braun Stiftung, a philanthropic foundation structurally separate from the reinsurance operations, focused on healthcare advancement. REVIUM operates as a classic captive reinsurer embedded inside an industrial family office, creating a structural advantage rarely found in third-party insurance portfolios. The vehicle converts underwriting float from B. Braun's core business into a permanent capital base for venture investing, eliminating the fundraising cycle that constrains independent VCs. This architecture gives the investment team patience and flexibility, allowing it to hold positions across the entire lifecycle of a company — from seed to late-stage — without external LP pressure. The arrangement mirrors other German industrial-family captives that have quietly built substantial venture portfolios behind operating company balance sheets.

Website
bbraun.com

General information

Firm type

Insurance

Year founded

2007

AUM

Micro (sub-$100M) (Altss estimate)

Location

Region

Europe

Country

Germany

City

Melsungen

Corporate office

Carl-Braun-Straße 1, 34212 Melsungen, Germany

Principals

Ludwig Georg Braun

Chairman of the Supervisory Board

Anna Maria Braun

Chief Executive Officer, B. Braun SE

Sector focus

Healthcare ServicesMedical Devices

Frequently asked questions

Who runs investment decisions at REVIUM Rückversicherung?

The firm has not publicly named its chief investment officer or disclosed its investment committee structure. REVIUM operates as a subsidiary of B. Braun SE, where sixth-generation family member Anna Maria Braun serves as CEO and her father, Ludwig Georg Braun, chairs the Supervisory Board. Day-to-day investment decisions likely flow through a team embedded within the Melsungen headquarters, reporting upward through the board.

Where does the underlying wealth come from?

The Braun family's wealth originates from B. Braun SE, a medical technology manufacturer founded in Melsungen in 1839. The company produces surgical instruments, hospital supplies, and healthcare equipment and generated €9.4 billion in sales in fiscal year 2025. The family is in its sixth generation of control.

How is REVIUM structured relative to B. Braun SE?

REVIUM Rückversicherung AG is a 100 percent subsidiary of B. Braun SE. It operates as the group's captive reinsurance company, providing insurance and reinsurance products to B. Braun entities and external clients while also managing an investment portfolio. This structure is not a separate family office but rather an operating subsidiary of the industrial parent.

What is REVIUM's known posture on venture investing?

The firm pursues a venture capital strategy spanning seed, start-up, expansion, and late-stage investments. It does not publicly disclose its portfolio companies, fund commitments, or co-investors. The mandate appears to be generalist, with no explicit sector restrictions announced, though the parent's medical technology focus may create a natural sector bias.

Does REVIUM maintain philanthropic structures?

The B. Braun Group operates the B. Braun Stiftung, a healthcare-focused foundation. REVIUM Rückversicherung is not directly involved in philanthropy — its mandate is reinsurance and investment — but both entities ultimately sit under the same family-controlled parent, B. Braun SE.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Melsungen Insurance profiles